LINAGLIPTIN
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | LINAGLIPTIN |
| DrugBank ID | DB08882 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 33 |
| DL Predictions (≥0.7) | 13 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| gastric ulcer (disease) | TxGNN Knowledge Graph | L5 |
| gastrin secretion abnormality | TxGNN Knowledge Graph | L5 |
| duodenal ulcer (disease) | TxGNN Knowledge Graph | L5 |
| hyperinsulinism (disease) | TxGNN Knowledge Graph | L5 |
| gastroesophageal reflux disease | TxGNN Knowledge Graph | L5 |
| zollinger-ellison syndrome | TxGNN Knowledge Graph | L5 |
| dyspepsia | TxGNN Knowledge Graph | L5 |
| peptic esophagitis | TxGNN Knowledge Graph | L5 |
| esophagitis (disease) | TxGNN Knowledge Graph | L5 |
| legionnaires' disease | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11